| 2334 |
1475: Decrease, Photosynthesis |
1472: Decrease, ATP production |
Apr 11, 2021 |
Apr 11, 2021 |
2 AOPs
|
| 2343 |
1475: Decrease, Photosynthesis |
1808: Decrease, ATP synthase activity |
Apr 11, 2021 |
Apr 11, 2021 |
None
|
| 1737 |
1517: Decrease, PSII activity |
1475: Decrease, Photosynthesis |
May 24, 2018 |
May 24, 2018 |
None
|
| 1740 |
1517: Decrease, PSII activity |
1364: Increase, ROS |
May 24, 2018 |
May 24, 2018 |
None
|
| 2333 |
1862: Decrease, Photosystem II efficiency |
1475: Decrease, Photosynthesis |
Apr 11, 2021 |
Apr 11, 2021 |
2 AOPs
|
| 2180 |
1810: Decrease, ATPase activity |
1768: Increase, Abnormal osmoregulation |
Nov 2, 2020 |
Nov 2, 2020 |
None
|
| 2756 |
2061: Decrease, Prevent chitin degradation by chitinases |
2062: Weak, Procuticle protection |
Aug 28, 2022 |
Aug 28, 2022 |
1 AOP
|
| 2336 |
1863: Decrease, Reproduction |
360: Decrease, Population growth rate |
Apr 11, 2021 |
Apr 11, 2021 |
5 AOPs
|
| 2556 |
1863: Decrease, Reproduction |
442: Decreased, Population trajectory |
Jan 21, 2022 |
Jan 21, 2022 |
1 AOP
|
| 769 |
771: Decrease, Serum thyroid hormone (T4/T3) |
753: Increase, Thyroid-stimulating hormone (TSH) |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 2735 |
2044: Decrease, SMO relocation |
2028: Decrease, GLI1/2 translocation |
Aug 23, 2022 |
May 22, 2023 |
1 AOP
|
| 2732 |
2043: Decrease, SHH second messenger production |
1821: Decrease, Cell proliferation |
Aug 23, 2022 |
Nov 14, 2023 |
2 AOPs
|
| 2733 |
2043: Decrease, SHH second messenger production |
1365: Increase, Apoptosis |
Aug 23, 2022 |
Aug 23, 2022 |
None
|
| 2957 |
2043: Decrease, SHH second messenger production |
1262: Apoptosis |
Jun 29, 2023 |
Jun 29, 2023 |
1 AOP
|
| 3060 |
2197: Decrease, sox10 |
352: N/A, Neurodegeneration |
Oct 17, 2023 |
Oct 17, 2023 |
1 AOP
|
| 2685 |
2020: Decrease, sox9 expression |
1559: Smaller and morphologically distorted facial cartilage structures |
Jun 30, 2022 |
Oct 20, 2022 |
1 AOP
|
| 2691 |
2020: Decrease, sox9 expression |
317: Altered, Cardiovascular development/function |
Jun 30, 2022 |
Oct 20, 2022 |
1 AOP
|
| 436 |
266: Decrease, Steroidogenic acute regulatory protein (STAR) |
447: Reduction, Cholesterol transport in mitochondria |
Nov 29, 2016 |
Dec 2, 2016 |
1 AOP
|
| 1547 |
1382: Decrease, surfactant |
1405: Reduced, mucosal defense |
Jun 2, 2017 |
Jun 2, 2017 |
1 AOP
|
| 2126 |
1690: Decrease, testosterone levels |
1613: Decrease, DHT level |
May 11, 2020 |
Oct 19, 2023 |
2 AOPs
|
| 2131 |
1690: Decrease, testosterone levels |
1614: Decrease, AR activation |
May 11, 2020 |
Apr 5, 2024 |
2 AOPs
|
| 3169 |
1690: Decrease, testosterone levels |
2212: Epididymal agenesis |
Mar 20, 2024 |
Apr 8, 2024 |
1 AOP
|
| 3202 |
1690: Decrease, testosterone levels |
809: malformed, Male reproductive tract |
Apr 25, 2024 |
Apr 25, 2024 |
1 AOP
|
| 3205 |
1690: Decrease, testosterone levels |
348: Malformation, Male reproductive tract |
May 1, 2024 |
May 1, 2024 |
1 AOP
|
| 3206 |
1690: Decrease, testosterone levels |
414: Increase, Luteinizing hormone (LH) |
May 1, 2024 |
May 1, 2024 |
1 AOP
|